Description:
TechnocloneAnti-PAI-1MonoclonalAntibody3PAI
IgG2b;halfmaximalbindingtocoatedPAI-1at10µg/ml;reactionwithactivePAI-1,latentPAI-1andt-PA-PAI-1complexes;nocross-reactionwithPAI-2orwithPAI-3;interfereswiththefunctionalactivityofPAI-1.ApplicationsincludeimmunodepletionofPAI-1fromhumanplasmainELISAtests.
Specificity
BindstoactivePAI-1,latentPAI-1andt-PA-PAI-1complexes.NobindingtoPAI-2orPAI-3.InterfereswiththefunctionalactivityofPAI-1.
Derivation
HybridizationofNSOcellswithspleencellsfromaBALB/cmouseimmunizedwithpurifiedPAI-1fromthehumanmelanomacelllineMJZJaccordingtothemethodofWagneretal.(1).
Antibodyclass
IgG2b
Purification
TheantibodyispurifiedfrommurineascitesbyaffinitychromatographyonimmobilizedrecombinantProteinA.ThepurityoftheproductistestedbyLaemmliSDS-PAGE.
Handlingandstorage:
Theantibodyislyophilizedfroma1mg/mlsolutioninisotonicphosphatebufferedsaline,pH7.4,containing0.02%sodiumazide.Itissuppliedinvialsof500µgandshouldbereconstitutedwith0.5mldistilledwater.Forextensivedilutionsaproteincontainingsolutionshouldbeused(e.g.1%bovineserumalbumininPBS).Lyophilizedantibodyshouldbestoredat4°C.Reconstitutedantibodyshouldbealiquotedandstoredat-20°Corlower.Avoidrepeatedfreeze-thawcycles.
Literature:
1)O.F.Wagner,M.Vetterlein,andB.R.Binder:Purificationofanactiveplasminogenactivatorinhibitorimmunologicallyrelatedtotheendothelialtypeplasminogenactivatorinhibitorfromtheconditionedmediaofahumanmelanomacellline.J.Biol.Chem.261:14474,1986.